Ovarian Cancer News & Features
The protein cytokeratin 5 (CK5), known to be a marker of poor prognosis in patients with breast cancer, also marks ovarian cancers likely to be resistant to the common chemotherapy cisplatin.
The more children a woman has or whether she has undergone tubal ligation lowers her risk of different types of ovarian cancer to different levels, according to new research presented at the 2015 NCRI Cancer Conference.
A healthy diet may reduce the risk for developing ovarian cancer in African American women.
Patients who develop ovarian cancer may have improved outcomes if they have prior oral contraceptive use.
Venlafaxine has a significant clinical activity against taxane-oxaliplatin-induced acute neurosensory toxicity in patients with cancer.
Ovarian Cancer Clinical Trials
- Gut Bacteria Can Dramatically Amplify Cancer Immunotherapy
- Existing Drug May Limit Recurrence and Metastasis of Glioblastoma Multiforme
- Blood Test Indicates Breast Cancer Tumors Developed Resistance to Hormone Treatment
- Breakthrough Advance Announced in International Blood Cancer Drug Trial
- Yoga May Reduce Side Effects in Patients Receiving Treatment for Prostate Cancer
- Breastfeeding Associated With A Reduced Risk of Aggressive Breast Cancer
- Hospitals Should Enact Bereavement Programs, Researchers Urge
- Physical Activity Communications Should be Part of Oncology Care Clinic Visits With Patients
- Communication Practices of Many US Physicians May Be Discouraging HPV Vaccination
- Chemo, Tamoxifen May Increase VTE Risk Among Patients With Breast Cancer
- New Blood Test Improves Screening for Prostate Cancer
- Concurrent Chemoradiotherapy Using Paclitaxel Plus Cisplatin in the Treatment of Elderly Patients With Esophageal Cancer
- International Study Charts Genetic Trajectory for Melanoma
- Risk of Several Autoimmune Diseases Increased in Childhood Cancer Survivors
- Protein Biomarker Assays for Diagnosing Thyroid Cancer May Show Inaccurate Readings
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|